Prof. Lukas Bubendorf is a surgical pathologist and head of cytopathology at the Institute for Pathology of the University Hospital Basel, Switzerland. He completed a post-doctoral research fellowship at the National Human Genome Research Institutes at the NIH, Bethesda, from 1998-2000.
He is a member of numerous national and international scientific societies, the Steering Committee of the ETOP Lungscape project, the IASLC Pathology Committee and the editorial boards of several journals including Journal of Thoracic Oncology, JTO Clinical and Research Reports, Lung Cancer, Pathobiology, Journal of Molecular Pathology, Cancer Cytopathology, Diagnostic Cytopathology, and Acta Cytologica.
Professor Bubendorf is the author of more than 300 papers in peer-reviewed journals and several book chapters. His major interests and diagnostic expertise lie within thoracic pathology and uropathology, and in the general field of cytopathology. His research group currently investigates the role of plasticity, genomic evolution and heterogeneity in solid tumors, including lung cancer. He also aims at translating molecular techniques and assays to clinical routine application.

Assistant Professor in Anatomic Pathology in School of Medicine, University of Naples Federico II.
Currently is the Chief Supervisor of Predictive Molecular Pathology Laboratory, Department of Public Health of University Federico II of Naples.
His main research interest is in the field of genomic biomarkers validation and testing for predictive information in the field of lung cancer, metastatic colorectal cancer, melanoma and gastrointestinal stromal tumor.
Moreover, he has developed skills in tailoring Next Generation Assays for a number of different applications with a special focus on the simultaneously detection of clinical relevant alterations (i.e., EGFR mutations, ALK traslocation, PD–L1 expression) in the routine setting including handling of different sample types, such as tissues and/or liquid biopsy specimens.